Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine

Clinical Pharmacology and Therapeutics

Volumn 80, Issue 5, 2006, Pages 440-456

  Oscarson, Mikael ^a   Zanger, Ulrich M ^a   Rifki, Oktay F ^a   Klein, Kathrin ^a   Eichelbaum, Michel ^a   Meyer, Urs A ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER B7; ABC TRANSPORTER C2; ALDOSTERONE RECEPTOR; BREAST CANCER RESISTANCE PROTEIN; CARBAMAZEPINE; CARBAMAZEPINE 10,11 OXIDE; CELL NUCLEUS RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR; CYTOCHROME P450; CYTOCHROME P450 1A; CYTOCHROME P450 2A; CYTOCHROME P450 2B; CYTOCHROME P450 2C; CYTOCHROME P450 3A; DRUG METABOLIZING ENZYME; GLUCOCORTICOID RECEPTOR; GLUCURONOSYLTRANSFERASE; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE Z1; ORGANIC ANION TRANSPORTER 1; PREGNANE X RECEPTOR; RNA; SULFOTRANSFERASE; SULFOTRANSFERASE 1A1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG METABOLISM; DRUG POTENCY; DRUG RESPONSE; DRUG TRANSPORT; ENZYME INDUCTION; EPILEPSY; FEMALE; GENE EXPRESSION PROFILING; GENE INDUCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; IC 50; IN VITRO STUDY; IN VIVO STUDY; LIVER; MALE; PRIORITY JOURNAL; SPECTRUM; TRANSACTIVATION; UPREGULATION;

EID: 33751092279     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clpt.2006.08.013     Document Type: Article

References (74)

1. Wilkinson G.R. Drug metabolism and variability among patients in drug response. N Engl J Med 352 (2005) 2211-2221
2. Chan L.M., Lowes S., and Hirst B.H. The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability. Eur J Pharm Sci 21 (2004) 25-51
3. Faber K.N., Muller M., and Jansen P.L. Drug transport proteins in the liver. Adv Drug Deliv Rev 55 (2003) 107-124
4. Kullak-Ublick G.A., Stieger B., and Meier P.J. Enterohepatic bile salt transporters in normal physiology and liver disease. Gastroenterology 126 (2004) 322-342
5. Bertilsson L., and Tomson T. Clinical pharmacokinetics and pharmacological effects of carbamazepine and carbamazepine-10,11-epoxide. An update. Clin Pharmacokinet 11 (1986) 177-198
6. Kerr B.M., Thummel K.E., Wurden C.J., Klein S.M., Kroetz D.L., Gonzalez F.J., et al. Human liver carbamazepine metabolism. Role of CYP3A4 and CYP2C8 in 10,11-epoxide formation. Biochem Pharmacol 47 (1994) 1969-1979
7. Kitteringham N.R., Davis C., Howard N., Pirmohamed M., and Park B.K. Interindividual and interspecies variation in hepatic microsomal epoxide hydrolase activity: studies with cis-stilbene oxide, carbamazepine 10, 11-epoxide and naphthalene. J Pharmacol Exp Ther 278 (1996) 1018-1027
8. Spina E., Pisani F., and Perucca E. Clinically significant pharmacokinetic drug interactions with carbamazepine. An update. Clin Pharmacokinet 31 (1996) 198-214
9. Kruse R. Osteopathies in antiepileptic long-term therapy (preliminary report) [in German]. Monatsschr Kinderheilkd 116 (1968) 378-381
10. Tunca A., Sayli U., Atalar H., and Dogruel H. Carbamazepine induced osteomalacia: letter to the editor. Acta Neurol Belg 105 (2005) 46-47
11. Klipstein F.A. Subnormal serum folate and macrocytosis associated with anticonvulsant drug therapy. Blood 23 (1964) 68-86
12. Apeland T., Mansoor M.A., Strandjord R.E., Vefring H., and Kristensen O. Folate, homocysteine and methionine loading in patients on carbamazepine. Acta Neurol Scand 103 (2001) 294-299
13. Rättyä J., Pakarinen A.J., Knip M., Repo-Outakoski M., Myllyla V.V., and Isojarvi J.I. Early hormonal changes during valproate or carbamazepine treatment: a 3-month study. Neurology 57 (2001) 440-444
14. LeCluyse E.L. Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation. Eur J Pharm Sci 13 (2001) 343-368
15. Wolbold R., Klein K., Burk O., Nussler A.K., Neuhaus P., Eichelbaum M., et al. Sex is a major determinant of CYP3A4 expression in human liver. Hepatology 38 (2003) 978-988
16. Irizarry R.A., Bolstad B.M., Collin F., Cope L.M., Hobbs B., and Speed T.P. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31 (2003) e15
17. Available from: URL:www.affymetrix.com. Accessed Oct 25, 2005.
18. Liu W.M., Mei R., Di X., Ryder T.B., Hubbell E., Dee S., et al. Analysis of high density expression microarrays with signed-rank call algorithms. Bioinformatics 18 (2002) 1593-1599
19. Handschin C., Podvinec M., and Meyer U.A. CXR, a chicken xenobiotic-sensing orphan nuclear receptor, is related to both mammalian pregnane X receptor (PXR) and constitutive androstane receptor (CAR). Proc Natl Acad Sci U S A 97 (2000) 10769-10774
20. Goodwin B., Hodgson E., and Liddle C. The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module. Mol Pharmacol 56 (1999) 1329-1339
21. Handschin C., and Meyer U.A. Induction of drug metabolism: the role of nuclear receptors. Pharmacol Rev 55 (2003) 649-673
22. Bertilsson L., Tybring G., Widen J., Chang M., and Tomson T. Carbamazepine treatment induces the CYP3A4 catalysed sulphoxidation of omeprazole, but has no or less effect on hydroxylation via CYP2C19. Br J Clin Pharmacol 44 (1997) 186-189
23. Gerbal-Chaloin S., Pascussi J.M., Pichard-Garcia L., Daujat M., Waechter F., Fabre J.M., et al. Induction of CYP2C genes in human hepatocytes in primary culture. Drug Metab Dispos 29 (2001) 242-251
24. Madan A., Graham R.A., Carroll K.M., Mudra D.R., Burton L.A., Krueger L.A., et al. Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes. Drug Metab Dispos 31 (2003) 421-431
25. Chen Y., Ferguson S.S., Negishi M., and Goldstein J.A. Identification of constitutive androstane receptor and glucocorticoid receptor binding sites in the CYP2C19 promoter. Mol Pharmacol 64 (2003) 316-324
26. Lakehal F., Wurden C.J., Kalhorn T.F., and Levy R.H. Carbamazepine and oxcarbazepine decrease phenytoin metabolism through inhibition of CYP2C19. Epilepsy Res 52 (2002) 79-83
27. Sotaniemi E.A., Rautio A., Backstrom M., Arvela P., and Pelkonen O. CYP3A4 and CYP2A6 activities marked by the metabolism of lignocaine and coumarin in patients with liver and kidney diseases and epileptic patients. Br J Clin Pharmacol 39 (1995) 71-76
28. Maglich J.M., Parks D.J., Moore L.B., Collins J.L., Goodwin B., Billin A.N., et al. Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes. J Biol Chem 278 (2003) 17277-17283
29. Wang H., Faucette S., Sueyoshi T., Moore R., Ferguson S., Negishi M., et al. A novel distal enhancer module regulated by pregnane X receptor/constitutive androstane receptor is essential for the maximal induction of CYP2B6 gene expression. J Biol Chem 278 (2003) 14146-14152
30. Denison M.S., and Nagy S.R. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol 43 (2003) 309-334
31. Maglich J.M., Stoltz C.M., Goodwin B., Hawkins-Brown D., Moore J.T., and Kliewer S.A. Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol Pharmacol 62 (2002) 638-646
32. Rae J.M., Johnson M.D., Lippman M.E., and Flockhart D.A. Rifampin is a selective, pleiotropic inducer of drug metabolism genes in human hepatocytes: studies with cDNA and oligonucleotide expression arrays. J Pharmacol Exp Ther 299 (2001) 849-857
33. Rosenberry K.R., Defusco C.J., Mansmann Jr. H.C., and McGeady S.J. Reduced theophylline half-life induced by carbamazepine therapy. J Pediatr 102 (1983) 472-474
34. Li-Hawkins J., Lund E.G., Bronson A.D., and Russell D.W. Expression cloning of an oxysterol 7alpha-hydroxylase selective for 24-hydroxycholesterol. J Biol Chem 275 (2000) 16543-16549
35. Shenoy S.D., Spencer T.A., Mercer-Haines N.A., Alipour M., Gargano M.D., Runge-Morris M., et al. CYP3A induction by liver X receptor ligands in primary cultured rat and mouse hepatocytes is mediated by the pregnane X receptor. Drug Metab Dispos 32 (2004) 66-71
36. Goodwin B., Gauthier K.C., Umetani M., Watson M.A., Lochansky M.I., Collins J.L., et al. Identification of bile acid precursors as endogenous ligands for the nuclear xenobiotic pregnane X receptor. Proc Natl Acad Sci U S A 100 (2003) 223-228
37. Dussault I., Yoo H.D., Lin M., Wang E., Fan M., Batta A.K., et al. Identification of an endogenous ligand that activates pregnane X receptor-mediated sterol clearance. Proc Natl Acad Sci U S A 100 (2003) 833-838
38. Rosenfeld J.M., Vargas Jr. R., Xie W., and Evans R.M. Genetic profiling defines the xenobiotic gene network controlled by the nuclear receptor pregnane X receptor. Mol Endocrinol 17 (2003) 1268-1282
39. Ueda A., Hamadeh H.K., Webb H.K., Yamamoto Y., Sueyoshi T., Afshari C.A., et al. Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital. Mol Pharmacol 61 (2002) 1-6
40. Benedetti M.S. Biotransformation of xenobiotics by amine oxidases. Fundam Clin Pharmacol 15 (2001) 75-84
41. Tukey R.H., and Strassburg C.P. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol 40 (2000) 581-616
42. Chung J.Y., Cho J.Y., Yu K.S., Kim J.R., Jung H.R., Lim K.S., et al. Effect of the UGT2B15 genotype on the pharmacokinetics, pharmacodynamics, and drug interactions of intravenous lorazepam in healthy volunteers. Clin Pharmacol Ther 77 (2005) 486-494
43. Levesque E., Turgeon D., Carrier J.S., Montminy V., Beaulieu M., and Belanger A. Isolation and characterization of the UGT2B28 cDNA encoding a novel human steroid conjugating UDP-glucuronosyltransferase. Biochemistry 40 (2001) 3869-3881
44. Sonoda J., Xie W., Rosenfeld J.M., Barwick J.L., Guzelian P.S., and Evans R.M. Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (PXR). Proc Natl Acad Sci U S A 99 (2002) 13801-13806
45. Duanmu Z., Locke D., Smigelski J., Wu W., Dahn M.S., Falany C.N., et al. Effects of dexamethasone on aryl (SULT1A1)- and hydroxysteroid (SULT2A1)-sulfotransferase gene expression in primary cultured human hepatocytes. Drug Metab Dispos 30 (2002) 997-1004
46. Fretland A.J., and Omiecinski C.J. Epoxide hydrolases: biochemistry and molecular biology. Chem Biol Interact 129 (2000) 41-59
47. Morel F., Fardel O., Meyer D.J., Langouet S., Gilmore K.S., Meunier B., et al. Preferential increase of glutathione S-transferase class alpha transcripts in cultured human hepatocytes by phenobarbital, 3-methylcholanthrene, and dithiolethiones. Cancer Res 53 (1993) 231-234
48. Falkner K.C., Pinaire J.A., Xiao G.H., Geoghegan T.E., and Prough R.A. Regulation of the rat glutathione S-transferase A2 gene by glucocorticoids: involvement of both the glucocorticoid and pregnane X receptors. Mol Pharmacol 60 (2001) 611-619
49. Tong Z., Board P.G., and Anders M.W. Glutathione transferase zeta-catalyzed biotransformation of dichloroacetic acid and other alpha-haloacids. Chem Res Toxicol 11 (1998) 1332-1338
50. Greiner B., Eichelbaum M., Fritz P., Kreichgauer H.P., von Richter O., Zundler J., et al. The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin. J Clin Invest 104 (1999) 147-153
51. Teng S., Jekerle V., and Piquette-Miller M. Induction of ABCC3 (MRP3) by pregnane X receptor activators. Drug Metab Dispos 31 (2003) 1296-1299
52. Kast H.R., Goodwin B., Tarr P.T., Jones S.A., Anisfeld A.M., Stoltz C.M., et al. Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J Biol Chem 277 (2002) 2908-2915
53. Payen L., Sparfel L., Courtois A., Vernhet L., Guillouzo A., and Fardel O. The drug efflux pump MRP2: regulation of expression in physiopathological situations and by endogenous and exogenous compounds. Cell Biol Toxicol 18 (2002) 221-233
54. Fromm M.F., Kauffmann H.M., Fritz P., Burk O., Kroemer H.K., Warzok R.W., et al. The effect of rifampin treatment on intestinal expression of human MRP transporters. Am J Pathol 157 (2000) 1575-1580
55. Chen Z.S., Robey R.W., Belinsky M.G., Shchaveleva I., Ren X.Q., Sugimoto Y., et al. Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport. Cancer Res 63 (2003) 4048-4054
56. Suzuki M., Suzuki H., Sugimoto Y., and Sugiyama Y. ABCG2 transports sulfated conjugates of steroids and xenobiotics. J Biol Chem 278 (2003) 22644-22649
57. Kaminski W.E., Wenzel J.J., Piehler A., Langmann T., and Schmitz G. ABCA6, a novel a subclass ABC transporter. Biochem Biophys Res Commun 285 (2001) 1295-1301
58. Taketani S., Kakimoto K., Ueta H., Masaki R., and Furukawa T. Involvement of ABC7 in the biosynthesis of heme in erythroid cells: interaction of ABC7 with ferrochelatase. Blood 101 (2003) 3274-3280
59. Fraser D.J., Zumsteg A., and Meyer U.A. Nuclear receptors constitutive androstane receptor and pregnane X receptor activate a drug-responsive enhancer of the murine 5-aminolevulinic acid synthase gene. J Biol Chem 278 (2003) 39392-39401
60. Rausch-Derra L.C., Hartley D.P., Meier P.J., and Klaassen C.D. Differential effects of microsomal enzyme-inducing chemicals on the hepatic expression of rat organic anion transporters, OATP1 and OATP2. Hepatology 33 (2001) 1469-1478
61. Staudinger J.L., Madan A., Carol K.M., and Parkinson A. Regulation of drug transporter gene expression by nuclear receptors. Drug Metab Dispos 31 (2003) 523-527
62. Ganapathy M.E., Huang W., Rajan D.P., Carter A.L., Sugawara M., Iseki K., et al. beta-Lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter. J Biol Chem 275 (2000) 1699-1707
63. Grube M., Meyer zu Schwabedissen H.E., Prager D., Haney J., Moritz K.U., Meissner K., et al. Uptake of cardiovascular drugs into the human heart: expression, regulation, and function of the carnitine transporter OCTN2 (SLC22A5). Circulation 113 (2006) 1114-1122
64. Pascussi J.M., Gerbal-Chaloin S., Drocourt L., Maurel P., and Vilarem M.J. The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle of networks of nuclear and steroid receptors. Biochim Biophys Acta 1619 (2003) 243-253
65. Jones S.A., Moore L.B., Wisely G.B., and Kliewer S.A. Use of in vitro pregnane X receptor assays to assess CYP3A4 induction potential of drug candidates. Methods Enzymol 357 (2002) 161-170
66. Sueyoshi T., Kawamoto T., Zelko I., Honkakoski P., and Negishi M. The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene. J Biol Chem 274 (1999) 6043-6046
67. Luo G., Cunningham M., Kim S., Burn T., Lin J., Sinz M., et al. CYP3A4 induction by drugs: correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes. Drug Metab Dispos 30 (2002) 795-804
68. Stevens J.C., Hines R.N., Gu C., Koukouritaki S.B., Manro J.R., Tandler P.J., et al. Developmental expression of the major human hepatic CYP3A enzymes. J Pharmacol Exp Ther 307 (2003) 573-582
69. Ripp S.L., Fitzpatrick J.L., Peters J.M., and Prough R.A. Induction of CYP3A expression by dehydroepiandrosterone: involvement of the pregnane X receptor. Drug Metab Dispos 30 (2002) 570-575
70. Fujita A., Furutama D., Tanaka T., Sakai R., Koyama A., Hanafusa T., et al. In vivo activation of the constitutive androstane receptor beta (CARbeta) by treatment with dehydroepiandrosterone (DHEA) or DHEA sulfate (DHEA-S). FEBS Lett 532 (2002) 373-378
71. Xie W., Barwick J.L., Downes M., Blumberg B., Simon C.M., Nelson M.C., et al. Humanized xenobiotic response in mice expressing nuclear receptor SXR. Nature 406 (2000) 435-439
72. Staudinger J.L., Goodwin B., Jones S.A., Hawkins-Brown D., MacKenzie K.I., LaTour A., et al. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci U S A 98 (2001) 3369-3374
73. Tateishi T., Asoh M., Nakura H., Watanabe M., Tanaka M., Kumai T., et al. Carbamazepine induces multiple cytochrome P450 subfamilies in rats. Chem Biol Interact 117 (1999) 257-268
74. Panesar S.K., Bandiera S.M., and Abbott F.S. Comparative effects of carbamazepine and carbamazepine-10,11-epoxide on hepatic cytochromes P450 in the rat. Drug Metab Dispos 24 (1996) 619-627